Emulsifiers’ Composition Modulates Venous Irritation of the Nanoemulsions as a Lipophilic and Venous Irritant Drug Delivery System
Tóm tắt
In this study, a nanoemulsion (NE) system was investigated for intravenous delivery of lipophilic and venous irritant drugs. NEs were prepared to deliver diallyl trisulfide (DT) for systemic therapy of bacterial and fungal infection, egg phospholipid was chosen as the main emulsifier, and two co-emulsifiers were also incorporated, including Poloxamer 188 (P188) and Solutol HS 15 (S15). Soybean oil was used as the dispersed phases, forming stable DT NEs with small particle sizes. The venous irritation of DT NEs was evaluated by in vitro human umbilical cord endothelial cells (CRL 1730) compatibility model with the intracellular adenosine triphosphate (ATP) and guanosine triphosphate (GTP) concentrations as the indices. The intracellular ATP and GTP reduction changed with the incorporation of a variety of co-emulsifiers, which varied in a free DT concentration-dependent manner. It was deduced that the free DT concentrations of NEs containing co-emulsifiers were determined by the partition coefficient of DT between oil and surfactant buffer solution. In conclusion, NE was an appropriate delivery system for lipophilic and venous irritant drug, and optimization of the composition of emulsifiers was an effective method to alleviate the venous irritation of DT NEs.
Tài liệu tham khảo
Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108–109:303–18.
Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr Opin Colloid Interface Sci. 2005;10:102–10.
Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today. 1999;4:134–43.
Sarker DK. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv. 2005;2:297–310.
Brazeau GA, Cooper B, Svetic KA, Smith CL, Gupta P. Current perspectives on pain upon injection of drugs. J Pharm Sci. 1998;87:667–77.
Wang Y, Mesfin GM, Rodriguez CA, Slatter JG, Schuette MR, Cory AL, et al. Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion. Pharm Res. 1999;16:930–8.
Smirniotis V, Kotsis TE, Antoniou S, Kostopanagiotou G, Labrou A, Kourias E, et al. Incidence of vein thrombosis in peripheral intravenous nutrition: effect of fat emulsions. Clin Nutr. 1999;18:79–81.
Yalkowsky SH, Krzyzaniak JF, Ward GH. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci. 1998;87:787–96.
Kinoshita M, Morioka N, Takada M, Ozaki M. The injection pain of propofol with different emulsion. Masui. 2006;55:338–43.
Lu Y, Wang Y, Tang X. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E. Int J Pharm. 2008;346:47–56.
Tsao SM, Yin MC. In-vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. J Med Microbiol. 2001;50:646–9.
Liu WH, Hsu CC, Yin MC. In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid. Phytother Res. 2008;22:53–7.
Ariga T, Seki T. Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review. BioFactors. 2006;26:93–103.
Shen J, Davis LE, Wallace JM, Cai Y, Lawson LD. Enhanced diallyl trisulfide has in vitro synergy with amphotericin B against Cryptococcus neoformans. Planta Med. 1996;62:415–8.
Xie L, Zhuo S. Treatments of the phlebitis caused by the Dasuansu injection. Hai Xia Yi Xue. 2005;17:110–1.
Chee S, Tan W. Reducing infusion phlebitis in Singapore hospitals using extended life end-line filters. J Infus Nurs. 2002;25:95–104.
Lanbeck P, Odenholt I, Riesbeck K. Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother. 2004;53:174–9.
Ohmizo H, Obara S, Iwama H. Mechanism of injection pain with long and long-medium chain triglyceride emulsive propofol. Can J Anaesth. 2005;52:595–9.
Yamakage M, Iwasaki S, Satoh J, Namiki A. Changes in concentrations of free propofol by modification of the solution. Anesth Analg. 2005;101:385–8.
Ueki R, Tanimoto M, Tatara T, Tsujimoto S, Kaminoh Y, Tashiro C. Emulsion of flurbiprofen axetil reduces propofol injection pain due to a decrease in free propofol concentration. J Anesth. 2007;21:325–9.
Yoon KA, Burgess DJ. Effect of nonionic surfactant on transport of model drugs in emulsions. Pharm Res. 1996;13:433–9.
Chidambaram N, Burgess DJ. Effect of nonionic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. AAPS PharmSci. 2000;2:E30.
Chidambaram N, Burgess DJ. Mathematical modeling of surface-active and non-surface-active drug transport in emulsion systems. AAPS PharmSci. 2000;2:E31.
Jumaa M, Muller BW. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660–12-hydroxy-stearate: evaluation of accelerated and long-term stability. Eur J Pharm Biopharm. 2002;54:207–12.
Medlicott NJ, Foster KA, Audus KL, Gupta S, Stella VJ. Comparison of the effects of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC). J Pharm Sci. 1998;87:1138–43.
Stefanos KTWNRGW, Grammatikos I. Monitoring of intracellular ribonucleotide pools is a powerful tool in the development and characterization of mammalian cell culture processes. Biotechnol Bioeng. 1999;64:357–67.
Chidambaram N, Burgess DJ. A novel in vitro release method for submicron sized dispersed systems. AAPS PharmSci. 1999;1:E11.
Jumaa M, Muller BW. The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant. Int J Pharm. 1998;174:29–37.
Chansiri G, Lyons RT, Patel MV, Hem SL. Effect of surface charge on the stability of oil/water emulsions during steam sterilization. J Pharm Sci. 1999;88:454–8.
Hagerstrand H, Bobacka J, Bobrowska-Hagerstrand M, Kralj-Iglic V, Fosnaric M, Iglic A. Oxyethylene chain-cation complexation: nonionic polyoxyethylene detergents attain a positive charge and demonstrate electrostatic head group interactions. Cell Mol Biol Lett. 2001;6:161–5.
Hoover DM, Gardner JB, Timmerman TL, Klepfer JA, Laska DA, White SL, et al. Comparison of in vitro and in vivo models to assess venous irritation of parenteral antibiotics. Fundam Appl Toxicol. 1990;14:589–97.
Vorbach H, Weigel G, Robibaro B, Reiter M, Hlousek M, Armbruster C, et al. Endothelial purine content. An alternative model for testing antibiotic solutions for intravenous use. Adv Exp Med Biol. 1998;431:827–31.
Armbruster C, Robibaro B, Griesmacher A, Vorbach H. Endothelial cell compatibility of trovafloxacin and levofloxacin for intravenous use. J Antimicrob Chemother. 2000;45:533–5.
Martin FL, McLean AE. Adenosine triphosphate (ATP) levels in paracetamol-induced cell injury in the rat in vivo and in vitro. Toxicology. 1995;104:91–7.
Sznitowska M, Zurowska-Pryczkowska K, Janicki S, Jarvinen T. Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle. Int J Pharm. 1999;184:115–20.
Wu CC, Lii CK, Tsai SJ, Sheen LY. Diallyl trisulfide modulates cell viability and the antioxidation and detoxification systems of rat primary hepatocytes. J Nutr. 2004;134:724–8.
Hosokawa T, Yamauchi M, Yamamoto Y, Iwata K, Kato Y, Hayakawa E. Formulation development of a filter-sterilizable lipid emulsion for lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist. Chem Pharm Bull. 2002;50:87–91.
Bernardo FP, Saraiva PM. A theoretical model for transdermal drug delivery from emulsions and its dependence upon formulation. J Pharm Sci. 2008;97:3781–809.